Company Number: SC788370

Analysis Date: 2025-07-20 12:13 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   Arman Aesthetics Ltd is a newly incorporated private limited company operating in the dental practice sector. The company's financial statements for its first operational period show a modest positive net current asset position and shareholders' funds, indicating initial capitalization and liquidity. However, due to its early stage, limited financial history, and absence of profitability data, credit approval should be conditional on ongoing monitoring of trading performance and cash flow generation before extending significant credit facilities.

2. Financial Strength:
   The balance sheet as of 30 November 2024 reveals total current assets of £21,296 against current liabilities of £15,882, resulting in net current assets of £5,414. The company has no fixed assets reported, which is typical for a service-based startup. Shareholders' funds stand at £5,414, reflecting modest retained earnings and a small share capital of £100. The financial structure is sound for a start-up, with no long-term liabilities noted. However, the company’s equity base is small, and the absence of accumulated profits (due to startup status) limits financial resilience.

3. Cash Flow Assessment:
   Cash at bank is £14,595, representing a reasonable liquidity buffer relative to current liabilities of £15,882. Debtors of £6,701 indicate some receivables but also expose the company to collection risk. Directors’ current accounts show a slight negative balance, suggesting minor director funding or withdrawals. The company has no employees yet and minimal accrued expenses, which helps conserve cash. Overall, working capital management appears adequate but requires close scrutiny as the business scales.

4. Monitoring Points:

• Profitability and cash flow trends in subsequent accounting periods to confirm sustainable operations.
• Debtor aging and collection efficiency to mitigate credit risk.
• Changes in current liabilities, especially tax and accrued expenses, which may impact liquidity.
• Directors’ advances or withdrawals that could affect cash availability.
• Any capital injections or external funding that strengthen the equity base.
• Timely submission of future accounts and confirmation statements to ensure compliance.